MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicineSingle-dose 100 mg vial for intravenous use, approved for metastatic breast cancerLaunch expected to be ...

The FDA granted the approval of Hympavzi to Pfizer Inc. (Image Credits: Pixabay) The U.S. Food and Drug Administration (USFDA) approved Hympavzi (marstacimab-hncq) for patients suffering from ...

Christopher Lawrence “Bong” Go, former aide of ex-president Rodrigo Duterte, mulls filing a resolution to kickstart the Senate investigation into the Duterte administration’s drug war.

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to develop, manufacture and commercialise the drug candidate “SON-080” for the ...

from its shortage list, and, for the time being, would not pursue regulatory action against certain compounding pharmacies making copies of the drugs. The decision, disclosed in a court filing ...

The drug candidate was demonstrated to be well-tolerated and the pain and quality of life survey results suggested a potential for rapid improvement of peripheral neuropathy symptoms and post ...

The drug was well-tolerated, and the trial results suggested potential for rapid improvement in peripheral neuropathy symptoms and long-lasting effects compared to a placebo. Akhilesh Sharma ...

New Delhi, Oct 10 (PTI) Alkem Laboratories Ltd on Thursday said it has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to develop, manufacture and commercialise a ...

Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for diabetic peripheral neuropathy in India. The drug has shown promising nerve ...

NEW DELHI, Oct 10 : He was one of the world’s most influential industrialists yet he never appeared on any list of billionaires. He controlled 30 companies that operated in over 100 countries across ...